Find a Doctor

Schedule Appointment

Find a Doctor

Schedule Appointment

Eugene F. Yen, M.D.

Eugene F. Yen, M.D.

Eugene F. Yen, M.D.

Log into NorthShoreConnect
Schedule Appointment

Profile

Personal Bio

Treatment Philosophy

I have specialty training in colon cancer prevention and the management of patients with Inflammatory Bowel Disease. In addition, I am actively involved in research in microscopic colitis as well as Clostridium difficile infection. I lead an active research team and am also involved in clinical trials for ulcerative colitis and Crohn’s disease. I pride myself on being readily accessible to accommodate the needs of my patients, and am involved in educating my peers as well as patients on the complex nature of IBD.

Conditions & Procedures

Conditions

Celiac Disease, Colitis, Collagenous Colitis, Colorectal Cancer, Crohn's Disease, Inflammatory Bowel Disease (IBD), Lymphocytic Colitis, Microscopic Colitis, Pregnancy and Inflammatory Bowel Disease (IBD), Ulcerative Colitis

Procedures

Barryx, Bravo Placement, Chromoendoscopy, Colonoscopy, Confocal Laser Endomicroscopy, Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Retrograde Cholangiopancreatography (ERCP) with sphinterotomy and/or stent placement, Esophageal Stent Placement, Flexible Sigmoidoscopy, Radiofrequency Ablation, Small Bowel Enteroscopy, Tumor Ablation, Upper Endoscopy

General Information

Gender

Male

Affiliation

NorthShore Medical Group

Expertise

Crohn's Disease, Ulcerative Colitis, Microscopic Colitis

Academic Rank

Clinical Assistant Professor

Languages

English

Board Certified

Gastroenterology, Internal Medicine

Education, Training & Fellowships

Medical School

Tufts University, School of Medicine, 2001

Internship

Barnes-Jewish Hospital, 2002

Residency

Barnes-Jewish Hospital, 2004

Fellowship

University of California San Francisco, 2007

Locations

A

NorthShore Medical Group

1000 Central St.
Suite 615
Evanston, IL 60201
847.657.1900 847.733.5041 fax Get Directions This location is wheelchair accessible.
B

NorthShore Medical Group

2150 Pfingsten Rd.
Suite 3000
Glenview, IL 60026
847.657.1900 847.570.5041 fax Get Directions This location is wheelchair accessible.

Insurance

For behavioral health services, please confirm participation with your insurance company or provider.

2017 Exchange Plans (Individuals)

 
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Ambetter Insured By Celtic
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Blue Basic PPO A Multi-State Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Blue Choice Preferred PPO (All Plans)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Blue FocusCare HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Blue Precision HMO (All Plans)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield Blue Premier PPO A Multi-State Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Blue Solution PPO A Multi-State Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield BlueCare Direct with Advocate HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Cigna Connect HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Cigna Connect HSA
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 

Off Exchange Plans (Individuals)

 
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Bronze Deductible Only HSA Eligible Savings Plus OAMC PD
Not Available In 2017
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Leap Everday Value Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Aetna Leap Everyday Carelink Centegra Health System
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Aetna Savings Plus OAMC PD (All Metal Tiers)
Not Available In 2017
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Whole Health Chicago (All Metal Tiers)
Not available for 2017
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Whole Health Chicago Bronze Deductible Only HSA Eligible
Not available for 2017
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Ambetter Insured By Celtic
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Blue Choice Preferred PPO (All Plans)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Blue Choice Preferred Security PPO 100
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Blue Cross Blue Premier 101 Multi-State Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Blue Cross Blue Shield Basic 103 Multi-State Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Blue Precision HMO (all plans)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield Blue Precision Platinum HMO 104
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield BlueCare Direct with Advocate
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Solution 102 Multi-State Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Coventry $15 Copay: Silver & Gold
Not Available In 2017
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Coventry Bronze $10 Copay Carelink St. John's
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Coventry Bronze $15 Copay Carelink St. John's
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Coventry Bronze $20 Copay
Not Available In 2017
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Coventry Bronze Deductible Only HSA Eligible
Not Available In 2017
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Harken Health - an Affiliate of United Healthcare
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Health Alliance HMO (All Metal Tiers)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Health Alliance POS (All Metal Tiers)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Health Alliance PPO (All Metal Tiers)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Humana Chicago HMOx (All Metal Tiers)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Humana Illinois HMOx
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
United Health One Golden Rule
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
United Healthcare Compass (All Plans)
Not Available In 2017
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 

Employer Sponsored Plans

 
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Choice POS II
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Health Network Only
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Managed Choice
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Network Options
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Open Access Aetna Select
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Open Access Managed Choice
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Open Choice PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Savings Plus
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Select
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Sub- Cofinity
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Sub- First Health
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Traditional Choice-Indemnity Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Whole Health Chicago (All Metal Tiers)
For employers with 2-50 employees
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Beechstreet PPO Network
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield Blue Advantage HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield Blue Choice Options PPO (All Metal Tiers)
Participating in Tier 2, there may be higher out of pocket costs
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield Blue Choice Preferred PPO (All Plans)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Blue Choice Select PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Blue Choice Select Value Choice
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Blue Distinction Total Care Benefit Differentail
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield Blue PPO (All Metal Tiers)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield Blue Precision HMO Plans (All Metal Tiers)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield BlueCare Direct (All Metal Tiers)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield BlueEdge HSA and BlueEdge HCA
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield BluePrint
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield Community Participating Option
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield HMOI
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield PPO Value Choice
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna Exclusive Provider Organization EPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna Great West Healthcare (GWH) Cigna Network
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna HMO Open Access
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna HMO Open Access POS
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna HMO POS
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna Medical PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna Medical Indemnity
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna Medical LocalPlus
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna Medical LocalPlus In-Network
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna Medical Network
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna Medical Network POS
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna Medical Open Access Plus (OAP)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna Medical Open Access Plus (OAP) In-Network
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna Medical Open Access POS
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cofinity PPO (an Aetna Company)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Coventry Consumer Choices (C3)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Coventry HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Coventry POS
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Coventry PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Galaxy Health Network
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Harken Health
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Health Alliance HMO, PPO, POS, POS-C
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Health Link HMO
If Unicare Affiliate logo present on card
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Health Link PPO
If Unicare Affiliate logo present on card
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Health Link-Open Access I, II, III
If Unicare Affiliate logo present on card
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Healthcare's Finest Network- FHN 10 & 20
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Healthcare's Finest Network- FHN Platinum
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Healthcare's Finest Network- HFN Community Health Connect
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Healthcare's Finest Network- HFN Community Health Connect Elite
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Healthcare's Finest Network- HFN Community Health Connect Premiere
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Healthcare's Finest Network- HFN-ID
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Advocate Centered EPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Humana Advocate Centered HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Humana Choice POS
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Classic Plan (Traditional Indemnity Plan)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Coinsurance: NPOS
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Coinsurance: PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Coinsurance:HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Condell Custom PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Humana Copay: HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Copay: NPOS
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Copay: PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana COT National POS-Open Access
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Edward- Elmhurst Value HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Humana Edward-Elmhurst Advantage HSA/Choice PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Humana High-deductible plans (HDHP) HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana High-deductible plans (HDHP) National point of service (NPOS)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana High-deductible plans (HDHP) PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Illinois Coordinated Care
Available In 2017
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Level Funded Premium
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana NorthShore Complete Care
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Self Funding: Administrative Services Only (ASO)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Self-Funding: Level Funded Premium (LFP)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Self-Funding: Minimum Premium (MP)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Self-Funding: Stop Loss Insurance
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Simplicity (HMO, POS, PPO)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Total Health (100 or more employees)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Multiplan/ PHCS- Health EOS Network
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Multiplan/ PHCS- MultiPlan Complementary
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Multiplan/ PHCS- MultiPlan Limited Benefit Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Multiplan/ PHCS- MultiPlan Practitioner Only
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Multiplan/ PHCS- MultiPlan Shared Savings
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
Multiplan/ PHCS- PHCS Healthy Directions
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Multiplan/ PHCS- PHCS Practitioner Only
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Multiplan/ PHCS- PHCS Savility
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Multiplan/ PHCS- ValuePoint by MultiPlan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
NorthShore Employee Network
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Preferred Network Access
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Preferred Plan- HealthSmart Get Better
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Preferred Plan PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Stratose- National Preferred Provider Network
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
Three Rivers Provider PPO Network (TRPN)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
UniCare HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
UniCare HMO Performance Select
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Unicare PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
UniCare Travel Access
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
United Health One Golden Rule
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
United Healthcare Catalyst
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
United Healthcare Charter
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
United Healthcare Choice
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
United Healthcare Choice Plus
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
United Healthcare Core
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
United Healthcare Heritage
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
United Healthcare Multi-Choice
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
United Healthcare Navigate and Navigate Plus
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
United Healthcare Options Non-Differential PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
United Healthcare Options PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
United Healthcare Tiered Benefits
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 

Medicaid

 
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Better Health FHP
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
Aetna Better Health ICP
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
Blue Cross Blue Shield Community FHP
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Community ICP
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Cigna HealthSpring ICP
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Community Care Alliance- ICP
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Family Health Network- FHP
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
Harmony/WellCare FHP Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
Humana ICP
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Illinicare Family Health Plan (FHP/ACA)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Illinicare ICP
Primary Care- Current Patients Only
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Illinois Department of Public Aid (IDPA)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Meridian FHP/ACA Expansion
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Meridian ICP
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Molina ICP
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Next Level ACA/FHP
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 

Medicare and Medicare Advantage Plans

 
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Medicare (SM) Plan (HMO)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Medicare (SM) Plan (PPO)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Medicare Advantage Group Plans
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Medicare Connect Plus (PPO)/PPO Connect Plus
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Medicare Standard Plan (PPO)/PPO Standard Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Medicare Value Plan (HMO)/HMO Value
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Medicare Value Plan (PPO)/PPO Value Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Traditional Choice Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield Medicare Advantage Basic HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Medicare Advantage Basic Plus HMO-POS
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Medicare Advantage Choice Plus PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield Medicare Advantage Choice Premier PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Blue Cross Blue Shield Medicare Advantage Premier Plus HMO-POS
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Cigna-HealthSpring Advantage HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna-HealthSpring Premier HMO-POS
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna-HealthSpring Primary HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna-HealthSpring TotalCare HMO-SNP
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Community Care Alliance Complete HMO-D-SNP
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Community Care Alliance HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Harmony/WellCare Access (HMO-SNP)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Harmony/WellCare Choice (HMO-POS)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Harmony/WellCare Health Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Harmony/WellCare RX (HMO)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Harmony/WellCare Value (HMO-POS)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Harmony/WellCare-Medicare HMO Plans
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Harmony/WellCare-Medicare Special Needs Plans
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Humana Choice PPO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Community HMO Diabetes and Heart (SNP Program)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Gold Plus HMO
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana Gold Plus PFFS
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Medicare - Part A and Part B
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Meridian Medicare Advantage
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Molina Medicare Advantage
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
United Healthcare - AARP Medicare Complete
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
United Healthcare AARP Medicare Complete Access
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
United Healthcare- AARP Medicare Complete Plus (HMO-POS)
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
United Healthcare Medicare Advantage Focus
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
United Healthcare- Medicare Solutions/Medicare Advantage
PRIMARY CARE
SPECIALTY CARE
HOSPITALS

Medicare Medicaid Alignment Initiative (MMAI) Plans

 
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Aetna Better Health MMAI
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Community MLTSS/LTSS
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Blue Cross Blue Shield Community MMAI
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Cigna-HealthSpring MMAI
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Humana MMAI
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Illinicare MLTSS/LTSS
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 
Illinicare MMAI
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Meridian MMAI
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Molina MMAI
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
 

Medicare Supplemental Plans

 
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
Medicare Supplemental Plans
These plans are secondary to Traditional Medicare; we accept all supplemental plans. Please confirm your coverage benefits with your supplemental carrier.
PRIMARY CARE
SPECIALTY CARE
HOSPITALS

Coverage For Active Military

 
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
TRICARE For Life
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
TRICARE Prime
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
TRICARE Prime Overseas
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
TRICARE Prime Remote
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
TRICARE Prime Remote Overseas
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
TRICARE Reserve Select
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
TRICARE Retired Reserve
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
TRICARE Standard and Extra
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
TRICARE Standard Overseas
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
TRICARE US Family Plan
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 
TRICARE Young Adult
PRIMARY CARE
SPECIALTY CARE
HOSPITALS
 
 

Publications

  • The Incidence of Microscopic Colitis: Microscopic No More.

    Digestive diseases and sciences 2017 Jun

    Authors: Radosevich AJ, Mutyal NN, Eshein A, Nguyen TQ, Gould B, Rogers JD, Goldberg MJ, Bianchi LK, Yen EF, Konda V, Rex DK, Van Dam J, Backman V, Roy HK
    Abstract
    Colorectal cancer remains the second leading cause of cancer deaths in the United States despite being eminently preventable by colonoscopy via removal of premalignant adenomas. In order to more effectively reduce colorectal cancer mortality, improved screening paradigms are needed. Our group pioneered the use of low-coherence enhanced backscattering (LEBS) spectroscopy to detect the presence of adenomas throughout the colon via optical interrogation of the rectal mucosa. In a previous ex vivo biopsy study of 219 patients, LEBS demonstrated excellent diagnostic potential with 89.5% accuracy for advanced adenomas. The objective of the current cross-sectional study is to assess the viability of rectal LEBS in vivo.
    Measurements from 619 patients were taken using a minimally invasive 3.4-mm diameter LEBS probe introduced into the rectum via anoscope or direct insertion, requiring approximately 1 minute from probe insertion to withdrawal. The diagnostic LEBS marker was formed as a logistic regression of the optical reduced scattering coefficient [Formula: see text] and mass density distribution factor D.
    The rectal LEBS marker was significantly altered in patients harboring advanced adenomas and multiple non-advanced adenomas throughout the colon. Blinded and cross-validated test performance characteristics showed 88% sensitivity to advanced adenomas, 71% sensitivity to multiple non-advanced adenomas, and 72% specificity in the validation set.
    We demonstrate the viability of in vivo LEBS measurement of histologically normal rectal mucosa to predict the presence of clinically relevant adenomas throughout the colon. The current work represents the next step in the development of rectal LEBS as a tool for colorectal cancer risk stratification.
    PMID: 28168580 [PubMed - as supplied by publisher]

  • Non-IBD colitides (eosinophilic, microscopic).

    Best practice & research. Clinical gastroenterology 2012 Oct

    Authors: Yen EF, Pardi DS
    Abstract
    Microscopic colitis includes the terms lymphocytic colitis and collagenous colitis, and is a common cause of chronic diarrhoea in older adults. The incidence of microscopic colitis has increased over time and has reached levels comparable to other forms of inflammatory bowel disease. In this chapter, an updated review on the epidemiology, diagnosis and treatment of microscopic colitis has been provided. There is limited data available about eosinophilic colitis, which is the least common of the eosinophilic GI disorders. It is important to rule out the secondary causes of colonic eosinophilia in patients with suspected eosinophilic colitis.
    PMID: 23384806 [PubMed - as supplied by publisher]

  • Current and past cigarette smoking significantly increase risk for microscopic colitis.

    Inflammatory bowel diseases 2012 Oct

    Authors: Yen EF, Pokhrel B, Du H, Nwe S, Bianchi L, Witt B, Hall C
    Abstract
    Cigarette smoking is an important environmental factor affecting inflammatory bowel disease. The role of smoking has not been rigorously studied in microscopic colitis (MC). The aim of this study was to compare the association of cigarette smoking in individuals with MC compared to a control population without MC.
    We reviewed the records of patients with a clinical and histologic diagnosis of collagenous colitis (CC) or lymphocytic colitis (LC). Clinical history, including alcohol and smoking status at the time of diagnosis of MC, were reviewed. In this case-control study, age- and gender-matched patients without diarrhea presenting for outpatient colonoscopy served as the control population.
    We analyzed a total of 340 patients with MC: 124 with CC and 216 with LC. Overall, any smoking status (former or current) was associated with MC (odds ratio [OR] 2.12, 95% confidence interval [CI]: 1.56-2.88). This risk was more prominent in current smokers (adjusted OR 5.36, 3.81, and 4.37 for CC, LC, and all MC, respectively, 95% CI all greater than 1). The association of smoking was not significantly affected by gender or average alcohol consumption.
    In our study population, cigarette smoking is a risk factor for the development of both forms of microscopic colitis. There were no significant differences between LC and CC, and current smoking and the development of microscopic colitis affected men and women similarly. We feel that these data are sufficient to discuss the potential risks of tobacco use in patients with microscopic colitis.
    PMID: 22147506 [PubMed - as supplied by publisher]

  • Decreased colorectal cancer and adenoma risk in patients with microscopic colitis.

    Digestive diseases and sciences 2012 Jan

    Authors: Yen EF, Pokhrel B, Bianchi LK, Roy HK, Du H, Patel A, Hall CR, Witt BL
    Abstract
    Microscopic colitis is currently considered to harbor no increased risk for colorectal cancer, based on a few small studies with limited long-term follow-up. Our aim was to identify patients with microscopic colitis, and to compare long-term rates of colorectal cancer or adenoma to a control group of patients without microscopic colitis.
    We reviewed the records of patients diagnosed with microscopic colitis, as identified by a hospital-based pathology database from January 2000 to August 2008. Clinical factors, including history of adenoma or adenocarcinoma, and all colonoscopy findings, were recorded. Age and gender-matched patients without microscopic colitis served as the control in a 1:1 fashion.
    A total of 647 patients (153 male: 494 female) were identified with microscopic colitis (MC). Any history of colorectal cancer was detected in 1.92, 1.81, and 4.17% of patients with collagenous colitis (CC), lymphocytic colitis (LC), and controls, respectively (P = 0.095, P = 0.040, P = 0.015 for CC, LC, and all MC, respectively, comparing to controls). Overall, covariate-adjusted risk (odds ratio) of any history of colorectal cancer and colorectal adenoma in MC patients was 0.34 (95% confidence interval [CI] 0.16-0.73, P = 0.006) and 0.52 (95% CI 0.50-0.76, P < 0.0001), respectively. The mean duration of follow-up was 4.63 years, with 147/647 (22.7%) of patients with clinical follow-up >7 years.
    In this case-control study involving a large retrospective cohort, microscopic colitis is negatively associated with the risk for colorectal cancer and adenoma. Further studies are required to determine a temporal relationship between microscopic colitis and the future development of colorectal neoplasia.
    PMID: 21847567 [PubMed - as supplied by publisher]

  • Review of the microscopic colitides.

    Current gastroenterology reports 2011 Oct

    Authors: Yen EF, Pardi DS
    Abstract
    Microscopic colitis is a common cause of chronic diarrhea in predominantly older adults. Incidence rates of microscopic colitis (including lymphocytic and collagenous colitis) have increased over time to levels comparable to other forms of inflammatory bowel disease. The possibility of drug-induced microscopic colitis is an important consideration when evaluating these patients, although this concept requires further investigation. There are few controlled treatment trials in microscopic colitis, with much of the data on treatment coming from retrospective studies. In patients with microscopic colitis, a systematic approach to therapy often leads to satisfactory control of symptoms. In this review, we will provide an updated assessment of the epidemiology, diagnosis, and treatment of microscopic colitis.
    PMID: 21773709 [PubMed - as supplied by publisher]

  • Review article: Microscopic colitis--lymphocytic, collagenous and 'mast cell' colitis.

    Alimentary pharmacology & therapeutics 2011 Jul

    Authors: Yen EF, Pardi DS
    Abstract
    Microscopic colitis is a relatively common cause of chronic diarrhoea in predominantly older adults, traditionally termed lymphocytic colitis and collagenous colitis. Increased mast cells found in the colonic biopsies of some patients with chronic diarrhoea may represent a distinct type of microscopic colitis.
    To provide an updated review of the epidemiology, diagnosis and treatment of microscopic colitis, and to discuss the role of mast cells in the gastrointestinal tract and their potential role in cases of functional diarrhoea.
    A MEDLINE literature search was performed to identify pertinent articles. Relevant clinical abstracts were also reviewed.
    Incidence rates of microscopic colitis (lymphocytic and collagenous colitis) have increased over time, to levels comparable with other forms of inflammatory bowel disease. The possibility of drug-induced microscopic colitis and concomitant coeliac sprue are important considerations when evaluating these patients. There are few controlled treatment trials in microscopic colitis, with much of the data on treatment coming from retrospective studies. Mast cells have been implicated in functional bowel disorders, with increased mast cells possibly contributing to cases of otherwise unexplained chronic diarrhoea, although this concept requires further investigation.
    In patients with microscopic colitis, a systematic approach to therapy often leads to satisfactory control of symptoms. The role of mast cells in chronic diarrhoea represents an evolving field, with the potential to offer alternative treatment pathways in patients with otherwise unexplained functional diarrhoea.
    PMID: 21545473 [PubMed - as supplied by publisher]

  • Cost-effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in ulcerative colitis.

    The American journal of gastroenterology 2008 Dec

    Authors: Yen EF, Kane SV, Ladabaum U
    Abstract
    Oral 5-aminosalicylic acid (5-ASA, mesalamine) is effective in inducing and maintaining remission in ulcerative colitis (UC). The relative benefits and costs of maintenance 5-ASA therapy are uncertain. Our aims were to evaluate this strategy's potential cost-effectiveness.
    We constructed a Markov model to compare two strategies over 2 yr: (a) no maintenance 5-ASA, with 5-ASA 4.8 g/day given for flares, (b) maintenance 5-ASA 2.4 g/day, escalated and maintained at 4.8 g/day after the first flare. In both arms, the failure to induce remission led to other treatments, as needed: prednisone, parenteral corticosteroids, cyclosporine, 6-mercaptopurine, infliximab, and colectomy.
    Without maintenance 5-ASA, the mean flares per person were 1.92, and the mean cost per person was $3,402. With maintenance 5-ASA providing a relative risk of flare of 0.7 at 5-ASA cost of $198/month, flares per person decreased to 1.38 at a cost of $8,810/flare prevented. Maintenance 5-ASA increased discounted quality-adjusted life-years per person (QALYs per person) from 1.75 to 1.77 at a discounted cost of $224,000/QALY gained. The results were most sensitive to the flare risk reduction and cost of 5-ASA, the utilities of being in remission without or with 5-ASA, and the colectomy rates. At $15/month (the cost of sulfasalazine), maintenance 5-ASA cost $640/flare prevented and $16,300/QALY gained.
    Maintenance 5-ASA therapy decreases UC flares, but its cost may be substantial, depending on society's willingness to pay. If sulfasalazine can be tolerated and yields comparable benefits, sulfasalazine maintenance therapy is likely to be cost-effective. The cost per QALY gained by 5-ASA maintenance is highly dependent on the quality of life while taking versus not taking maintenance 5-ASA, highlighting the importance of patients' preferences.
    PMID: 18775007 [PubMed - as supplied by publisher]

  • Colonoscopic treatment of acute diverticular hemorrhage using endoclips.

    Digestive diseases and sciences 2008 Sep

    Authors: Yen EF, Ladabaum U, Muthusamy VR, Cello JP, McQuaid KR, Shah JN
    Abstract
    Although colonoscopy is used in the diagnostic evaluation of patients with diverticular hemorrhage, data on colonoscopic treatment outcomes are limited. We reviewed records of inpatients undergoing colonoscopy to identify patients that were colonoscopically diagnosed and treated for acute diverticular hemorrhage. Eleven patients with acute diverticular hemorrhage had active bleeding (n = 7) or non-bleeding visible vessel (n = 4) at colonoscopy. Endoclip treatment (preceded by epinephrine injection in 64%) achieved hemostasis in all patients without procedural complications. Patients were discharged within three days without evidence of early rebleeding. During a median follow-up of 15 months, late recurrent bleeding occurred in two patients (18.2%). Colonoscopic treatment of patients with acute diverticular hemorrhage using endoclips appears to be effective and safe, with high rates of immediate and long-term success. Colonoscopy should be considered in patients with suspected acute diverticular hemorrhage, as it may enable definitive therapy without the need for more invasive treatment.
    PMID: 18157637 [PubMed - as supplied by publisher]

  • Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004 Oct

    Authors: Yen EF, Hardinger K, Brennan DC, Woodward RS, Desai NM, Crippin JS, Gage BF, Schnitzler MA
    Abstract
    Unless they maintain Medicare status through disability or age, kidney transplant recipients lose their Medicare coverage of immunosuppression 3 years after transplantation. A significant transplant survival advantage has previously been demonstrated by the extension of Medicare immunosuppressive medication coverage from 1 year to 3 years, which occurred between 1993 and 1995. The United States Renal Data System (USRDS) was analyzed for recipients of kidney transplants from 1995 to 1999. Using a Markov model, we estimated survival and costs of the current system of 3-year coverage compared with lifetime immunosuppression coverage. Results were calculated from the perspectives of society and Medicare. Extension of immunosuppression coverage produced an expected improvement from 38.6% to 47.6% in graft survival and from 55.4% to 61.8% in patient survival. The annualized expected savings to society from lifetime coverage was $136 million assuming current rates of transplantation. Medicare would break-even compared with current coverage if the fraction of patients using extended coverage was <32%. The extension would be cost-effective to Medicare if this fraction was <91%. Extended Medicare immunosuppression coverage to the life of a kidney transplant should result in better transplant and economic outcomes, and should be considered by policy makers.
    PMID: 15367228 [PubMed - as supplied by publisher]
View more results at PubMed.gov

Social Media

Featured Videos

Dr. Eugene Yen discusses IBD risks and treatment options during pregnancy.

Dr. Eugene Yen discusses IBD risks and treatment options during pregnancy.

Dr. Eugene Yen explains the differences and similarities between Chrohn's and Ulcerative Colitis.

Dr. Eugene Yen explains the differences and similarities between Chrohn's and Ulcerative Colitis.

Dr. Eugene Yen give an overview of IBD, covering symptoms and who is at risk.

Dr. Eugene Yen give an overview of IBD, covering symptoms and who is at risk.

Dr. Eugene Yen discusses the risks of colon cancer among IBD patients.

Dr. Eugene Yen discusses the risks of colon cancer among IBD patients.

Dr. Eugene Yen talks about different treatment therapies for IBD patients.

Dr. Eugene Yen talks about different treatment therapies for IBD patients.